Literature DB >> 1693381

Monoclonal antibodies against two discrete determinants on Vi capsular polysaccharide.

A Qadri1, S Ghosh, G P Talwar.   

Abstract

Vi is a linear homopolymer of 1,4 N-acetyl galactosaminuronic acid. It is present in S. typhi and some other members of Enterobacteriaceae. Vi antigen of S. typhi has been associated with the virulence of the organism and a vaccine based upon this antigen has been found to confer immunity against typhoid. In this paper, we report production and characterization of four hybrid cell clones secreting monoclonal antibodies against Vi capsular polysaccharide. Binding analysis using different derivatives of Vi showed that three monoclonal antibodies reacted with the antigenic determinant constituted by O-acetyl group and one recognised the epitope constituted by N-acetyl and carboxyl groups together. All the antibodies bound to Vi positive strains of S. typhi and did not show any significant reactivity with Vi negative strains of S. typhi, S. paratyphi A, S. paratyphi B and E. coli. Besides their utility in studying the sub-specificity of antibodies produced after vaccination with Vi, these antibodies would be helpful in the diagnosis of typhoid fever.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693381     DOI: 10.1080/01971529008053271

Source DB:  PubMed          Journal:  J Immunoassay        ISSN: 0197-1522


  11 in total

1.  Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Soo-Young Wanda; Cheryl A Nickerson; Roy Curtiss
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

2.  Identification of specific recognition molecules on murine mononuclear phagocytes and B lymphocytes for Vi capsular polysaccharide: modulation of MHC class II expression on stimulation with the polysaccharide.

Authors:  A Qadri
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

3.  Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.

Authors:  Amita Sharma; Ayub Qadri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

4.  Unique lipid anchor attaches Vi antigen capsule to the surface of Salmonella enterica serovar Typhi.

Authors:  Sean D Liston; Olga G Ovchinnikova; Chris Whitfield
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

5.  Molecular characterization of the viaB locus encoding the biosynthetic machinery for Vi capsule formation in Salmonella Typhi.

Authors:  Michael Wetter; David Goulding; Derek Pickard; Michael Kowarik; Charles J Waechter; Gordon Dougan; Michael Wacker
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

6.  Periplasmic depolymerase provides insight into ABC transporter-dependent secretion of bacterial capsular polysaccharides.

Authors:  Sean D Liston; Stephen A McMahon; Audrey Le Bas; Michael D L Suits; James H Naismith; Chris Whitfield
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

7.  The Virulence Polysaccharide of Salmonella Typhi Suppresses Activation of Rho Family GTPases to Limit Inflammatory Responses From Epithelial Cells.

Authors:  Farhat Parween; Jitender Yadav; Ayub Qadri
Journal:  Front Cell Infect Microbiol       Date:  2019-05-08       Impact factor: 5.293

8.  MyD88-dependent pro-inflammatory activity in Vi polysaccharide vaccine against typhoid promotes Ab switching to IgG.

Authors:  Rohini Garg; Ajay Suresh Akhade; Jitender Yadav; Ayub Qadri
Journal:  Innate Immun       Date:  2015-08-24       Impact factor: 2.680

9.  Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2008-12-01       Impact factor: 0.968

10.  Host lipid sensing promotes invasion of cells with pathogenic Salmonella.

Authors:  Sonia Shivcharan; Jitender Yadav; Ayub Qadri
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.